Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

Are There Risks of Cannabinoid Hyperemesis in Underweight Anorexia Users? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Though rare, some patients develop a condition called cannabinoid hyperemesis syndrome (CHS), marked by severe nausea and vomiting. This raises concerns about cannabinoid hyperemesis in anorexia, especially for those who are already underweight and medically fragile. 

For individuals with anorexia, such complications could worsen malnutrition and delay recovery. 

Medical Cannabis: Alternative to pain relief?

Understanding The Risks Of CHS 

CHS is linked to prolonged or heavy cannabis use, and its risks may be heightened in vulnerable patients. 

Underweight Risk 

Patients with anorexia face a unique underweight risk, as persistent vomiting can further deplete already low nutrient and fluid reserves, increasing the danger of complications. 

Vomiting 

The main symptom of CHS is repeated vomiting, often resistant to standard treatments. In underweight patients, this can quickly lead to dangerous imbalances. 

Safety Concerns 

Overall safety concerns make it vital to monitor cannabis use in anorexia carefully. Early recognition of symptoms and medical intervention are essential if CHS develops. 

In summary, while rare, cannabinoid hyperemesis in anorexia is a serious risk. Patients should only use cannabis under clinical supervision, with close attention to dosage and symptom monitoring. 

Visit providers like LeafEase for expert guidance on safe cannabis use and managing risks in anorexia care. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Anorexia

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories